These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Structural and Molecular Imaging for Clinically Uncertain Parkinsonism. Sasikumar S; Strafella AP Semin Neurol; 2023 Feb; 43(1):95-105. PubMed ID: 36878467 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Perlmutter JS; Norris SA Ann Neurol; 2014 Dec; 76(6):769-83. PubMed ID: 25363872 [TBL] [Abstract][Full Text] [Related]
8. Assessment of Parkinson disease: what do we need to show neuroprotection? Ybot-Gorrin I; Vivancos-Matellano F; Chacón-Peña JR; Alonso-Navarro H; Jiménez-Jiménez FJ Neurologist; 2011 Nov; 17(6 Suppl 1):S21-9. PubMed ID: 22045322 [TBL] [Abstract][Full Text] [Related]
9. Structural MRI in Idiopathic Parkinson's Disease. De Micco R; Russo A; Tessitore A Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605 [TBL] [Abstract][Full Text] [Related]
11. Neuroimaging in Parkinsonian Disorders. Tripathi M; Kumar A; Bal C Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329 [TBL] [Abstract][Full Text] [Related]
12. Neuroimaging of depression in Parkinson's disease: a review. Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107 [TBL] [Abstract][Full Text] [Related]
13. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease. Mak E; Su L; Williams GB; O'Brien JT Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683 [TBL] [Abstract][Full Text] [Related]
14. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894 [TBL] [Abstract][Full Text] [Related]
15. The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes. Holtbernd F; Eidelberg D Semin Neurol; 2014 Apr; 34(2):202-9. PubMed ID: 24963679 [TBL] [Abstract][Full Text] [Related]
16. Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease. Wen MC; Chan LL; Tan LCS; Tan EK Acta Neurol Scand; 2017 Aug; 136(2):84-96. PubMed ID: 28670700 [TBL] [Abstract][Full Text] [Related]
17. Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. Kalia LV; Lang AE Nat Rev Neurol; 2016 Feb; 12(2):65-6. PubMed ID: 26782330 [No Abstract] [Full Text] [Related]
18. Biomarkers in Parkinson's disease: Advances and strategies. Delenclos M; Jones DR; McLean PJ; Uitti RJ Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946 [TBL] [Abstract][Full Text] [Related]
19. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Ecker C; Bookheimer SY; Murphy DG Lancet Neurol; 2015 Nov; 14(11):1121-34. PubMed ID: 25891007 [TBL] [Abstract][Full Text] [Related]